Equity alert: rosen law firm announces filing of securities class action lawsuit against acer therapeutics inc. – acer

New york--(business wire)--rosen law firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of acer therapeutics inc. (nasdaq: acer) from september 25, 2017 through june 24, 2019, inclusive (the “class period”). the lawsuit seeks to recover damages for acer investors under the federal securities laws. to join the acer class action, go to http://www.rosenlegal.com/cases-register-1611.html or call phillip kim, esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. no class has yet been certified in the above action. until a class is certified, you are not represented by counsel unless you retain one. you may retain counsel of your choice. you may also remain an absent class member and do nothing at this point. an investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. according to the lawsuit, defendants throughout the class period made false and/or misleading statements and/or failed to disclose that: (i) acer lacked sufficient data to support filing edsivo’s new drug application (“nda”) with the fda for the treatment of veds; (ii) the ong trial, a 2004 study acer heavily relied on its submission of edsivo’s nda, was an inadequate and ill-controlled clinical study by fda standards, and was comprised of an insufficiently small group size to support edsivo’s nda; (iii) consequently, the fda would likely reject edsivo’s nda; and (3) as a result, defendants’ statements about acer’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. when the true details entered the market, the lawsuit claims that investors suffered damages. a class action lawsuit has already been filed. if you wish to serve as lead plaintiff, you must move the court no later than august 30, 2019. a lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. if you wish to join the litigation, go to http://www.rosenlegal.com/cases-register-1611.html or to discuss your rights or interests regarding this class action, please contact phillip kim, esq. of rosen law firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or cases@rosenlegal.com. follow us for updates on linkedin: https://www.linkedin.com/company/the-rosen-law-firm, on twitter: https://twitter.com/rosen_firm or on facebook: https://www.facebook.com/rosenlawfirm/. rosen law firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. rosen law firm was ranked no. 1 by iss securities class action services for number of securities class action settlements in 2017. the firm has been ranked in the top 3 each year since 2013. rosen law firm has secured hundreds of millions of dollars for investors.
ACER Ratings Summary
ACER Quant Ranking